The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma WH Yang, CKC Ding, T Sun, G Rupprecht, CC Lin, D Hsu, JT Chi Cell reports 28 (10), 2501-2508. e4, 2019 | 264 | 2019 |
Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress G LaMonte, X Tang, JLY Chen, J Wu, CKC Ding, MM Keenan, ... Cancer & metabolism 1, 1-19, 2013 | 183 | 2013 |
A TAZ–ANGPTL4–NOX2 Axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer WH Yang, Z Huang, J Wu, CKC Ding, SK Murphy, JT Chi Molecular Cancer Research 18 (1), 79-90, 2020 | 172 | 2020 |
Suppression of PGC-1α is critical for reprogramming oxidative metabolism in renal cell carcinoma EL LaGory, C Wu, CM Taniguchi, CKC Ding, JT Chi, R von Eyben, ... Cell reports 12 (1), 116-127, 2015 | 160 | 2015 |
Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism PH Chen, J Wu, CKC Ding, CC Lin, S Pan, N Bossa, Y Xu, WH Yang, ... Cell Death & Differentiation 27 (3), 1008-1022, 2020 | 157 | 2020 |
MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis CKC Ding, J Rose, T Sun, J Wu, PH Chen, CC Lin, WH Yang, KY Chen, ... Nature Metabolism 2 (3), 270-277, 2020 | 108 | 2020 |
Cystine deprivation triggers programmed necrosis in VHL-deficient renal cell carcinomas X Tang, J Wu, CK Ding, M Lu, MM Keenan, CC Lin, CA Lin, CC Wang, ... Cancer Research 76 (3), 2016 | 82 | 2016 |
A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells B Chu, F Liu, L Li, C Ding, K Chen, Q Sun, Z Shen, Y Tan, C Tan, Y Jiang Cell death & disease 6 (3), e1686-e1686, 2015 | 70 | 2015 |
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling X Tang, CK Ding, J Wu, J Sjol, S Wardell, I Spasojevic, D George, ... Oncogene 36 (30), 4235-4242, 2017 | 51 | 2017 |
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway CC Lin, WH Yang, YT Lin, X Tang, PH Chen, CKC Ding, DC Qu, ... Oncogene 40 (11), 2018-2034, 2021 | 47 | 2021 |
Zinc transporter ZIP7 is a novel determinant of ferroptosis PH Chen, J Wu, Y Xu, CKC Ding, AA Mestre, CC Lin, WH Yang, JT Chi Cell death & disease 12 (2), 198, 2021 | 45 | 2021 |
Identification of Chiari Type I Malformation subtypes using whole genome expression profiles and cranial base morphometrics CA Markunas, E Lock, K Soldano, H Cope, CKC Ding, DS Enterline, ... BMC medical genomics 7 (1), 1-15, 2014 | 32 | 2014 |
The regulation of ferroptosis by MESH1 through the activation of the integrative stress response CC Lin, CKC Ding, T Sun, J Wu, KY Chen, P Zhou, JT Chi Cell Death & Disease 12 (8), 727, 2021 | 22 | 2021 |
Erratum: Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling X Tang, CK Ding, J Wu, J Sjol, S Wardell, I Spasojevic, D George, ... Oncogene 36 (30), 4379-4379, 2017 | 22 | 2017 |
Coda-19: Using a non-expert crowd to annotate research aspects on 10,000+ abstracts in the covid-19 open research dataset THK Huang, CY Huang, CKC Ding, YC Hsu, CL Giles arXiv preprint arXiv:2005.02367, 2020 | 17 | 2020 |
LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression. SL Xu, C Ding, CC MA, TS Yuan, CC Hua, XH Wang European Review for Medical & Pharmacological Sciences 25 (2), 2021 | 12 | 2021 |
Mammalian stringent-like response mediated by the cytosolic NADPH phosphatase MESH1 CKC Ding, J Rose, J Wu, T Sun, KY Chen, PH Chen, E Xu, S Tian, ... Biorxiv, 325266, 2018 | 12 | 2018 |
CODA-19: reliably annotating research aspects on 10,000+ CORD-19 abstracts using a non-expert crowd C Huang, CC Ding, Y Hsu, CL Giles | 6 | 2020 |
Suppression of PGC-1a Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma EL LaGory, C Wu, CM Taniguchi, CKC Ding, JT Chi, R von Eyben, ... Cell Reports 12 (4), 717, 2015 | 4 | 2015 |
Prostate cancer in male-to-female transgender individuals: histopathologic findings and association with gender-affirming hormonal therapy E Baraban, CKC Ding, M White, P Vohra, J Simko, K Boyle, C Guo, ... The American Journal of Surgical Pathology 46 (12), 1650-1658, 2022 | 3 | 2022 |